A Randomized, Phase II, Clinical Trial of Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable, Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma. Ann Surg Oncol 2023 Feb;30(2):688-690
Date
11/26/2022Pubmed ID
36427115DOI
10.1245/s10434-022-12742-3Scopus ID
2-s2.0-85145451354Author List
Saif A, Verbus E, Erickson B, Kamgar M, Tsai S, Evans D, Hernandez JM, Hall WAAuthors
Beth A. Erickson MD Professor in the Radiation Oncology department at Medical College of WisconsinWilliam Adrian Hall MD Associate Professor in the Radiation Oncology department at Medical College of Wisconsin
Mandana Kamgar MD Assistant Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AdenocarcinomaAntineoplastic Combined Chemotherapy Protocols
Fluorouracil
Humans
Neoadjuvant Therapy
Pancreatic Neoplasms
Radiosurgery
